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We have investigated the relationship in human cultured normal and malignant melanocytes between the accumulation of mRNAs encoding 
tyrosinase and tyrosinase-related protein-l (TRP-I), the activity of tyrosinase and the presence of melanin. Tyrosinase mRNA correlates with 
tyrosinase activity and with the presence of pheomelanin, eumelanin or both melanin types. In contrast TRP-1 mRNA is only detectable in cells 
containing eumelanin, which suggests a role for TRP-1 in the eumelanin synthesis pathway. 
Brown; Tyrosinase; Melanogenesis; Human 
1. INTRODUCTION 
Epidermal melanocytes are highly differentiated cells 
which are derived from the neural crest, and responsible 
for basal skin color and tanning. They produce two 
types of melanin: eumelanins (brown or black), and 
pheomelanins (red or yellow). The key enzyme in the 
biosynthesis of both pigments is tyrosinase (EC 
1.14.8. l), which catalyses the hydroxylation of tyrosine 
to DOPA and the oxidation of DOPA to dopaquinone 
[l]. Recently, two melanocyte-s~ci~c cDNAs have 
been cloned, which were both candidates for encoding 
tyrosinase [2,3]. One of the genes proved to be tyrosi- 
nase, and has now been mapped to the c locus on mouse 
chromosome 7 [3] and to human chromosome 11 (q14- 
q21). The other is assigned to the brown (b) locus on 
mouse chromosome 4 [4] and to hman chromosome 9 
[5]. The protein encoded by this gene is now termed 
tyrosinase-related protein 1 (TRPl) or Brown. Human 
and mouse TRPl are 93% identical and they differ in 
length by ten amino acids at the carboxyl terminus 161. 
The enzymatic role of TRPl is not clear, and di~erent 
enzymatic functions have been postulated: dopachome 
tautomerase [4J, DHI conversion factor 191, melano- 
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somal catalase [lo] or even another tyrosinase [l 11. In 
mouse, it has been shown that TRPl is required for the 
formation of black rather than brown eumelanin [7]. 
Slominski et al. reported a high abundance of the pro- 
tein TRPl in a pigmented (eumelanic) hamster mela- 
noma but a low one in a pheomelanotic cell line [8]. 
Recently, Vijayasaradhi et al. [12] have demonstrated 
that a human melanoma antigen known as gp75 is iden- 
tical to TRPlIBrown. Interestingly, the presence of 
gp75 has been associated with visible pi~en~tion of 
human melanoma cells [13]. In the present work, we 
have examined in more detail the relationship between 
tyrosinase and TRPllBrown mRNA accumulation, ty- 
rosinase activity and the presence of eumelanins or 
pheomelanins. 
2. MATERIALS AND METHODS 
2.1. Cells 
All melanoma cell lines (HBL, SCL, LNDl, DOR, BEU, IGR3) 
studied were cultured in Ham FlO medium supplemented with 10% 
fbetal calf serum and 1% ~nicillin-streptomy~n solution (10,~ UI 
ml-10,000 &ml), 1% kanamycin solution (10,000 yglmt), and 1% 
glutamine (200 mM) as previously described [14]. Normal melanocytes 
were cultured in Ham FlO medium as previously described by Smit 
et al. [IS]. DOR, BEU cell lines were originally a gift from Dr. J.F. 
Dore (INSERM, Lyon) and IGR3 were provided by Dr. C. Aubert 
(Marseille). SCCI is a human squamous cell carcinoma (of the floor 
of the mouth) used as a control. 
2.2. Tyrosine hydroxyiase assay 
Tyrosinase was extracted from 8.5 x lo6 cells in 1 ml HBSS, after 
homogenisation and sonication. Crude extracts were divided into two 
lots: one was used to estimate the melanin content and its type (AHP 
and PTCA) [16] and the total protein content of this extract as de- 
scribed below. Tbe other was treated with NP40 (1% final concentra- 
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tion), centrifuged at 10,000 x g for 10 min and the supematant was 
used to measure tyrosine hydroxylase activity, as described by Jara et 
al. [16]. One unit of tyrosine hydroxylase was defined as the amount 
of enzyme that catalyses the hydroxylation of 1 pmol L-tyrosine per 
min. In each experiment, results were normalised according to the 
protein content of the cell extract, determined by the method described 
by Lowry et al. [17’J. 
2.3. Quantitative analysis of eumelanin and pheomelanin 
The concentrations of eumelanin and pheomelanin in the cell ex- 
tracts were determined by HPLC according to the method described 
by Ito and Fujita [18]. Permanganate oxidation of eumelanin to 
pyrrola2,3,5-tricarboxylic a id (PTCA) and hydriodic acid hydrolysis 
of pheomelanin to aminohydroxyphenylalanine (AHP) were used to 
estimate pigment content. 
2.4. Northern blot 
Northern blots were performed as described by Wathelet et al. [19]. 
cDNAs corresponding to human tyrosinase and TRPl genes (clones 
BBTY-1, and gp 8, a gift from B. Bouchard, Memorial Sloan-Ketter- 
ing Cancer Center, New York, USA) were radiolabelled with 
[32P]dCTP using a commercial Multiprime DNA labelling kit (Amer- 
sham). To confirm that equal quantities of RNA were efficiently 
transferred to nylon membranes the Northern blots were re-probed 
with a 28s rRNA probe (data not shown). 
2.5. PCR 
The published sequences of mouse and human tyrosinase [3,7l and 
TRP-1 [2,6] and mouse TRP-2 [20] were examined to identify peptide 
motifs in common to all five. Degenerate oligonucleotide primers were 
designed, based on these motifs, which should allow simultaneous 
amplification by the polymerase chain reaction of all three cDNA 
sequences. The primer sequences are: 
S-GCACTCGAGAYGAY(C/A)GIGAGARIINTGGCC-3 
which will prime from any cDNA encoding the peptide DDREXWP 
and is flanked by an XhoI site; and: 
5’-TAGGAGCTC(T/G)RTTRTGICCIATNGGNGC-3 
which will prime the complementary strand of any cDNA encoding 
the peptide APIGHNR, and is flanked by an SstI site. (R = G + A, 
Y = C + T, I = inosine, N = all four bases, bases in parentheses are 
both included). Synthesis of double-stranded cDNA used a kit from 
Boehringer Mannheim according to their instructions, using random 
hexamer primers, and 1 ,ug total cellular RNA as substrate. 10% of 
the product was used in a polymerase chain reaction as previously 
described [20] with 3 pg/ml final primer concentration. The reaction 
was denatured at 94°C for 2 min, then cycled 5 times through 92”C, 
1 min, 42°C 1 min and 72”C, 2.5 min, followed by 30 cycles of 92°C. 
1 min, 48°C 1 min, 72”C, 2.5 min. The reaction products were analy- 
sed by restriction endonuclease digestion and gel electrophoresis. 
3. RESULTS AND DISCUSSION 
Table I shows the melanogenic phenotypes of a num- 
ber of normal melanocytes and melanoma cells in cul- 
ture. Detectable tyrosinase activity (tyrosine hydrox- 
ylase) appears to be associated with the presence of 
melanin regardless of the type of melanin as determined 
by HPLC analysis. Our results also show that a clear 
pigmentation of the cells is observed only when 
eumelanins are detectable. Even when large amounts of 
pheomelanin alone are present there is no visible pig- 
mentation (as seen with the LNDl and BEU cell lines). 
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Fig. 1. Northern blot analysis of RNA from melanoma cell lines. Total 
RNA (5 pg) extracted from the melanoma cell line was analysed by 
Northern blot with either the tyrosinase (A) probe (Fig. la) or TRP-1 
probe (Fig. lb). The probe used is indicated by the arrow on the left 
(A = tyrosinase, TRP-1, tyrosinase related protein 1). 1, SCL; 2, HBL; 
3, LNDl; 4, BEU; 5, IGR3; 6, DOR; 7, SCCl. Lanes 1-6 correspond 
to human melanoma cells RNAs. SCCl is a human lingual carcinoma 
used as control. 
On the other hand, it should be noted that both types 
of melanin are present in some of the cell lines tested 
(HBL) and in normal melanocytes. It also appears that 
the melanin content of normal melanocytes is much 
higher than that of melanoma cells. However, although 
the normal melanocytes and the melanoma cell lines 
were grown in the same tyrosine (10 PM) containing 
medium, the growth of the normal melanocytes addi- 
tionally requires the presence of TPA (30 nM), cholera 
toxin (2 nM) and IBMX (0.1 mM). It thus remains to 
be seen if one or several of these agents is responsible 
for the high melanin content. It may also be that the 
slower growth rate of these cells allows a higher accu- 
mulation of intracellular melanin. 
To investigate any relationship between tyrosinase 
and TRPl gene expression and their role in melano- 
genesis, we analyzed the accumulation of the transcrip- 
tion products of these two genes by Northern blotting 
(Fig. 1) and by PCR amplification (Fig. 2). The human 
TRP-1 cDNA sequence contains a BumHI site, absent 
from tyrosinase, which will cut the amplified cDNA into 
two fragments of 550 and 510 bp. Fig. 2 (PCR) shows 
that the diagnostic TRP-1 BumHI cleavage doublet was 
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Fig. 2. Agarose gel electrophoresis of PCR-amplified cDNAs. odd numbered tracks are 10 ~1 undigested PCR products, even numbered tracks 
are 25 ~1 product digested with BumHI. M = @X174 Hue111 marker. (1,2) MNGHM; (3,4) MNWC; ($6) MNKB; (7,8) SCL; (9,lO) HBL; (11,12) 
LNDI; (13,14) BEU; (1516) IGR3; (17,18) DOR. SCCl was used as a human non-melanocytic ontrol (data not shown). The arrow on the left 
indicates the diagnostic TRP-1 BarnHI doublet. The arrow on the right indicates a faint PCR product present in all tracks except 15 and 16 which 
hybridises to the tyrosinase probe and is probably a spliced variant. 
present in a subset of cell RNAs, including the two 
shown by Northern blotting (Fig. 1) and detailed in 
Table I. Blotting of these gels and probing with a tyrosi- 
nase cDNA probe showed that in all except cell line 
IGR3, tyrosinase sequences were amplified (data not 
shown) again in agreement with Northern blot data. In 
normal and malignant melanocytes, tyrosinase mRNA 
appears to be associated with detectable tyrosinase ac- 
tivity and the presence of pheomelanin, eumelanin or 
both (Table I). However, TRPl mRNA accumulation 
is only found in the five cell lines (SCL, HBL, 
MNGHM, MNWC, MNKB) containing eumelanins. 
This finding strongly supports the idea of an involve- 
ment of this protein in eumelanogenesis. Mouse genetics 
data also supports this hypothesis. The yellow pigmen- 
tation of mutant mice which only produce pheomelanin 
such as lethal yellow (Ay) or extension (e) is not further 
affected by the brown (TRP-1) mutation, which only 
modifies the colour of eumelanin-producing mice. 
In conclusion, our results show that visible pigmenta- 
tion is correlated with eumelanin content and that in 
both normal and malignant human melanocytes, tyrosi- 
nase mRNA accumulation is associated with both de- 
tectable tyrosinase activity and measurable melanin 
content. In addition, we also show that TRPl mRNA 
is only detectable in eumelanin-containing cells. It sug- 
gests that in human melanocytes, TRPl is involved only 
in eumelanin and not in pheomelanin synthesis. The 
role that TRP-1 is playing remains to be defined. 
Table I 
Phenotypic and genotypic parameters measured in melanoma and normal melanocyte cells in culture 
Cell line Phenotypic expression Type Genotypic expression 
Tyrosine PTCA AHP Visible Tyrosinase TRPl 
hydroxylase (t&O6 cells) (r&O6 cells) pigment 
olU/mg) NB PCR NB PCR 
Melanoma 
IGR3 
DOR 
LNDl 
BEU 
HBL 
SCL 
Normal melanocytes 
MNGHM 
MNWC 
NHMKB 
Human carcinoma 
SSCl 
4 
66 + 35 
1,408 f 497 
242 f 32 
277 + 155 
200f 10 
654f 11 
1,057 + 103 
9042 18 
<5 
Cl 
<l 
<l 
<l 
14+ 3 
43 + 16 
136.5 f 3.5 
40.5 + 4 
178.5 ?r 32 
-=l 
<IO 
llf 3 
458 f 327 
373? 172 
103 + 43 
181 f 46 
1,144 + 206 
1,315 _+ 191 
1.675 f 77 
Cl0 
- Amelanotic 
- Weakly 
pheomelanotic 
- Pheomelanotic 
- Pheomelanotic 
+ Mixed type 
++ Mixed type 
+++ 
+++ 
+++ 
Mixed type 
Mixed type 
Mixed type 
Amelanotic 
ND + ND + 
ND + ND + 
ND + ND + 
- ND - ND 
The pigmentation was visually estimated by intensity of brown or black pigment in each cell pellet: -, absent; +, moderate; ++, high; +++, very 
high. The classification of melanogenesis type is based on the following criteria: Eumelanic, PTCA > 5 ng/106 cells and AHP > 10 @lo6 cells; 
Pheomelanic, AHP > 10 ng/106 cells and PTCA < 1 ng/106 cells; Amelanotic, PTCA < 1 ng/106 cells; AHP < 10 ng/106 cells; Mixed type, contain 
both pheomelanin (AHP > 10 ng/106 cells) and eumelanin (PTCA > 1 q/IO6 cells); NB, detection by Northern blot: +, detected; -, below detection; 
ND, not done; PCR, detection by polymerase chain reaction. 
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